Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05671107 · ClinicalTrials.gov registry record
Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients
A clinical trial of PTEN Hamartoma Tumor Syndrome, sponsored by John Carroll University.
- Completed
- Registry status
- 300
- Enrollment target
- 2
- Study locations
NCT05671107 is a study of PTEN Hamartoma Tumor Syndrome that has completed, run by John Carroll University. The registered enrollment target is 300 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT05671107, a study of PTEN Hamartoma Tumor Syndrome, has completed, sponsored by John Carroll University.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to develop a survey completed by parents, caregivers, or other informants that evaluates several important domains of functioning relevant to individuals with neurodevelopmental disorders, including autism spectrum disorder and people with genetic syndromes. Participation in this research will include assisting the research team in the development of the survey measures.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST NET
Study Locations (2)
Ohio
- John Carroll Univeristy - University Heights
Southampton
- University Hospital South Hampton - Hampton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-09-09 |
| Est. Completion | 2024-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05671107
The ClinicalTrials.gov registry entry for NCT05671107 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is John Carroll University, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PTEN Hamartoma Tumor Syndrome appearing as the primary indexed condition, and to 1 intervention - of which NET is the first listed.
NCT05671107 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Southampton.
Frequently Asked Questions
What is clinical trial NCT05671107 about?
NCT05671107 is a clinical study titled "Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients". The purpose of this study is to develop a survey completed by parents, caregivers, or other informants that evaluates several important domains of functioning relevant to individuals with neurodevelopmental disorders, including autism spectrum disorder and people with genetic syndromes. Participatio...
What is the current status of trial NCT05671107?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2021-09-09. Estimated completion is 2024-06-30.
What conditions does trial NCT05671107 study?
This clinical trial studies the following conditions: PTEN Hamartoma Tumor Syndrome.
What interventions are being tested in trial NCT05671107?
The interventions under investigation include: NET (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05671107?
This trial is sponsored by John Carroll University, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05671107 being conducted?
This trial has 2 study locations across Ohio, Southampton. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTEN Hamartoma Tumor Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.